Cancer

New Cancer Study Reveals Promising Anticancer Effects of Platinum Ribavirin

Strategic Insights

Jul 31, 2025 — 1 min read

Researchers at Islamic Azad University in Tehran, Iran, have conducted a study to assess the anticancer effects of Pt-Rb and Pt-AZT on HepG2 cells. The study aimed to compare the efficacy of these two compounds in inducing apoptosis and modulating gene expression. The results showed that Pt-Rb exhibited stronger anticancer effects, lower drug resistance, and fewer side effects compared to Pt-AZT.

Key Takeaways:

The study investigated the anticancer effects of Pt-Rb and Pt-AZT on HepG2 cells using various biomarkers, including miRNA-122, miRNA-21, telomerase, and Bcl-2.
Pt-Rb exhibited significant increases in proapoptotic gene miRNA-122 (19.97 ± 0.04) and decreases in antiapoptotic genes miRNA-21 (0.10 ± 0.014), telomerase (0.56 ± 0.480), and Bcl-2 (0.41 ± 0.276) compared to Pt-AZT.
The study concluded that Pt-Rb has more benefits in terms of stronger anticancer effects than Pt-AZT, with lower drug resistance and fewer side effects.
The research suggests that Pt-Rb can be a more effective anticancer therapy option.
The study highlights the importance of biomarkers such as miRNA-122, miRNA-21, telomerase, and Bcl-2 in assessing the anticancer effects of drugs.

Statistics:

The study showed a significant increase in the proapoptotic gene miRNA-122 in Pt-Rb-treated cells (19.97 ± 0.04) compared to Pt-AZT-treated cells (10.36 ± 0.007).
There was a significant decrease in the antiapoptotic genes in Pt-Rb-treated cells, including miRNA-21 (0.10 ± 0.014), telomerase (0.56 ± 0.480), and Bcl-2 (0.41 ± 0.276) compared to Pt-AZT-treated cells.
The study found that Pt-Rb has lower drug resistance and fewer side effects compared to Pt-AZT.

Sources:

Middle East Journal of Cancer, 2025,16(3):197-209.
Islamic Azad University, Department of Biochemistry, Faculty of Medicine, Tehran Medical Sciences.
Shiraz University of Medical Sciences, publisher of Middle East Journal of Cancer.
https://doi-org.sdpl.idm.oclc.org/10.30476/mejc.2025.104451.2183.

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients